Beta
44293

Antiphospholipid antibodies in chronic immune thrombocytopenic purpura in pediatric patients

Thesis

Last updated: 06 Feb 2023

Subjects

-

Tags

Pediatrics

Advisors

Qaddah, Nourmin A., El-Ghamrawi, Muna K., Muhammad, Hanan E.

Authors

El-Augail, Eiman Abdel-Lattif

Accessioned

2017-07-12 06:42:40

Available

2017-07-12 06:42:40

type

M.Sc. Thesis

Abstract

Idiopathic immune thrombocytopenic purpura (ITP) known as primary ITP or autoimmune thrombocytopenic purpura is defined as isolated thrombocytopenia with normal bone marrow in absence of other causes of thrombocytopenia . ITP is primarily a disease of increased peripheral platelets destruction, with most patients having antibodies to specific platelet membrane glycoproteins. In about 30% of cases of ITP, antiphospholipid antibodies (APLA) are present and in about 20% of antiphospholipid syndrome (APS), thrombocytopenia is detected. Interestingly, some ITP patients with persistent APLA may later develop thrombotic complications particularly when platelet count normalizes after corticosteroid therapy or splenectomy . It was suggested by some studies that the persistent presence of APLA in patients with ITP might be an important risk factor for the development of APS. Significantly high ACA IgM , ACA IgG and antiβ2glycoprotein IgG mean concentrations were found in chronic ITP cases compared with acute cases or controls .

Issued

1 Jan 2011

DOI

http://dx.doi.org/10.21473/iknito-space/38230

Details

Type

Thesis

Created At

31 Jan 2023